$22.64
0.261.16%
At close: -
iShares Genomics Immunology and Healthcare ETF (ARCA: IDNA)
Ticker | Name | Share % | |
---|---|---|---|
SM | Roche Holding A.G. | 4.71% | |
GILD | Gilead Sciences Inc | 4.62% | |
SRPT | Sarepta Therapeutics Inc | 4.53% | |
RVMD | Revolution Medicines Inc Ser C Pc Pp | 4.44% | |
INCY | Incyte Corp. | 4.32% | |
REGN | Regeneron Pharmaceuticals, Inc. | 4.23% | |
EXEL | Exelixis Inc | 4.21% | |
TK | Takeda Pharmaceutical Co Ltd | 4.16% | |
PA | Sanofi SA | 4.11% | |
HK | Beigene, Ltd. | 4.05% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
IDNA follows a Mid Cap Growth investment style.
The top holdings of IDNA include: SM (4.71%), GILD (4.62%), SRPT (4.53%), RVMD (4.44%), INCY (4.32%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for IDNA is currently not available.